Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms

Clinical trial NCT02150369 · COMPLETED

Trial details

NCT number: NCT02150369
Sponsor: Duke University
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Renal Cell Carcinoma Metastatic Melanoma High-dose Interleukin-2

Start date: 2015-02-16
Primary completion: 2017-03-02
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.